| Name | Title | Contact Details |
|---|---|---|
Eliot Lurier |
Interim CFO | Profile |
Chad Hymel |
Director of Supply Chain | Profile |
Ashley Cate |
Associate Director, Finance | Profile |
Preston Brown |
VP, Product Operations | Profile |
Khoi Le |
Senior Director of R&D, Software Development, Scientific Computing/Informatics | Profile |
Essential Group is a Gurnee, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Revance Therapeutics is a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions, including muscle movement disorders and pain. The company`s lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines, cervical dystonia and plantar fasciitis with the potential to be the first long-acting neuromodulator. Revance has developed a proprietary, stabilizing excipient peptide technology designed to create novel, differentiated therapies. The company has a comprehensive pipeline based upon its peptide technology, including injectable and topical formulations of daxibotulinumtoxinA.
Chitosan manufacturer and supplier of ready-to-use chitosan flocculants, textile treatments, and agricultural elicitor applications.
Prescos is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Michael is a Franklinton, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.